Terms: = Pancreatic cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
43 results:
1. Survival-Associated Cellular Response Maintained in pancreatic Ductal Adenocarcinoma (PDAC) Switched Between Soft and Stiff 3D Microgel Culture.
Atkins DJ; Rosas JM; Månsson LK; Shahverdi N; Dey SS; Pitenis AA
ACS Biomater Sci Eng; 2024 Apr; 10(4):2177-2187. PubMed ID: 38466617
[TBL] [Abstract] [Full Text] [Related]
2. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
Ha JL; Kaser E; Guan T; Mayberry TG; Smith LA; D'mello K; Bai Q; Wakefield MR; Dong L; Fang Y
Med Oncol; 2024 Jan; 41(3):65. PubMed ID: 38281234
[TBL] [Abstract] [Full Text] [Related]
3. The Novel Use of IL-28 as an Effective Radiosensitizer in pancreatic cancer.
Chen X; Lee HY; Tang TT; Qin C; Prissel SA; Nelson CJ; Smith LA; Xiao H; Bai Q; Nicholl MB; Wakefield MR; Fang Y
Anticancer Res; 2023 May; 43(5):1885-1890. PubMed ID: 37097692
[TBL] [Abstract] [Full Text] [Related]
4. Design, Synthesis, and Anti-cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine.
Zhang L; Qi K; Xu J; Xing Y; Wang X; Tong L; He Z; Xu W; Li X; Jiang Y
J Med Chem; 2023 Mar; 66(6):4150-4166. PubMed ID: 36867101
[TBL] [Abstract] [Full Text] [Related]
5. Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
de Mestier L; Nicolle R; Poté N; Rebours V; Cauchy F; Hentic O; Maire F; Ronot M; Lebtahi R; Sauvanet A; Paradis V; Ruszniewski P; Couvelard A; Cros J
J Pathol; 2022 Sep; 258(1):58-68. PubMed ID: 35681273
[TBL] [Abstract] [Full Text] [Related]
6. Determining Hospital Volume Threshold for Safety of Minimally Invasive pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
Conroy PC; Calthorpe L; Lin JA; Mohamedaly S; Kim A; Hirose K; Nakakura E; Corvera C; Sosa JA; Sarin A; Kirkwood KS; Alseidi A; Adam MA
Ann Surg Oncol; 2022 Mar; 29(3):1566-1574. PubMed ID: 34724124
[TBL] [Abstract] [Full Text] [Related]
7. Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis.
Wu W; Cheng Q; Chen J; Chen D; Feng X; Wu J
World J Surg Oncol; 2021 Apr; 19(1):107. PubMed ID: 33838682
[TBL] [Abstract] [Full Text] [Related]
8. Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis.
Mangieri CW; Strode MA; Moaven O; Clark CJ; Shen P
J Surg Oncol; 2020 Dec; 122(8):1604-1611. PubMed ID: 32935353
[TBL] [Abstract] [Full Text] [Related]
9. NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials.
Kapacee ZA; Knox JJ; Palmer D; Blagden SP; Lamarca A; Valle JW; McNamara MG
Med Oncol; 2020 Jun; 37(7):61. PubMed ID: 32529264
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.
Sadowski SM; Pieterman CRC; Perrier ND; Triponez F; Valk GD
Endocr Relat Cancer; 2020 Jun; 27(6):R145-R161. PubMed ID: 32229700
[TBL] [Abstract] [Full Text] [Related]
11. The CCR5 antagonist maraviroc causes remission of pancreatic cancer liver metastasis in nude rats based on cell cycle inhibition and apoptosis induction.
Huang H; Zepp M; Georges RB; Jarahian M; Kazemi M; Eyol E; Berger MR
Cancer Lett; 2020 Apr; 474():82-93. PubMed ID: 31954769
[TBL] [Abstract] [Full Text] [Related]
12. Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031.
Sarr A; Bré J; Um IH; Chan TH; Mullen P; Harrison DJ; Reynolds PA
Sci Rep; 2019 May; 9(1):7643. PubMed ID: 31113993
[TBL] [Abstract] [Full Text] [Related]
13. Expression of p27
Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
[TBL] [Abstract] [Full Text] [Related]
14. A hospital-to-home evaluation of an enhanced recovery protocol for elective pancreaticoduodenectomy in China: A cohort study.
Su W; Lu F; Zhang X; Li G; Chen W; Ma T; Gao S; Lou J; Bai X; Liang T
Medicine (Baltimore); 2017 Oct; 96(41):e8206. PubMed ID: 29019886
[TBL] [Abstract] [Full Text] [Related]
15. A reduced time to surgery within a 'fast track' pathway for periampullary malignancy is associated with an increased rate of pancreatoduodenectomy.
Roberts KJ; Prasad P; Steele Y; Marcon F; Faulkner T; Cilliers H; Dasari B; Abradelo M; Marudanayagam R; Sutcliffe RP; Muiesan P; Mirza DF; Isaac J
HPB (Oxford); 2017 Aug; 19(8):713-720. PubMed ID: 28566239
[TBL] [Abstract] [Full Text] [Related]
16. Obstructive Sleep Apnea and Pathological Characteristics of Resected pancreatic Ductal Adenocarcinoma.
Dal Molin M; Brant A; Blackford AL; Griffin JF; Shindo K; Barkley T; Rezaee N; Hruban RH; Wolfgang CL; Goggins M
PLoS One; 2016; 11(10):e0164195. PubMed ID: 27732623
[TBL] [Abstract] [Full Text] [Related]
17. (Ir)relevance of Metformin Treatment in Patients with Metastatic pancreatic cancer: An Open-Label, Randomized Phase II Trial.
Reni M; Dugnani E; Cereda S; Belli C; Balzano G; Nicoletti R; Liberati D; Pasquale V; Scavini M; Maggiora P; Sordi V; Lampasona V; Ceraulo D; Di Terlizzi G; Doglioni C; Falconi M; Piemonti L
Clin Cancer Res; 2016 Mar; 22(5):1076-85. PubMed ID: 26459175
[TBL] [Abstract] [Full Text] [Related]
18. Interplay between menin and Dnmt1 reversibly regulates pancreatic cancer cell growth downstream of the Hedgehog signaling pathway.
Cheng P; Wang YF; Li G; Yang SS; Liu C; Hu H; Jin G; Hu XG
Cancer Lett; 2016 Jan; 370(1):136-44. PubMed ID: 26454216
[TBL] [Abstract] [Full Text] [Related]
19. Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional concept.
Cannistrà M; Ruggiero M; Zullo A; Serafini S; Grande R; Nardo B
Int J Surg; 2015 Sep; 21 Suppl 1():S15-21. PubMed ID: 26123383
[TBL] [Abstract] [Full Text] [Related]
20. Identification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization.
Liang JW; Shi ZZ; Shen TY; Che X; Wang Z; Shi SS; Xu X; Cai Y; Zhao P; Wang CF; Zhou ZX; Wang MR
PLoS One; 2014; 9(12):e114616. PubMed ID: 25502777
[TBL] [Abstract] [Full Text] [Related]
[Next]
